Prexasertib (lactate)
Prexasertib lactate (LY2606368 lactate) is the lactate form of Prexasertib. Prexasertib lactate is a selective, ATP-competitive second-generation checkpoint kinase 1 (CHK1) inhibitor with a Ki of 0.9 nM and an IC50 of CHK2 (IC50=8 nM) and RSK1 (IC50=9 nM). Prexasertib lactate causes double-stranded DNA breakage and replication catastrophe resulting in apoptosis. Prexasertib lactate shows potent anti-tumor activity[1][2].
Product Specifications
CAS Number
2781996-46-9
Product Name Alternative
LY2606368 (lactate)
UNSPSC
12352005
Target
Apoptosis; Checkpoint Kinase (Chk) ; DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/prexasertib-lactate.html
Smiles
OC([C@@H](O)C)=O.NCCCOC1=C(C2=CC(NC3=NC=C(C#N)N=C3)=NN2)C(OC)=CC=C1
Molecular Formula
C21H25N7O5
Molecular Weight
455.47
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
Chk1; Chk2
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
